Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
chlorobutanol + lidocaine + paradichlorobenzene + turpentine oil
- Development stage
- Unknown
- Lead developer
- Med Manor Organics
- Modality
- Small Molecules
- Administration
- Otic
01
Overview
Otoid is a combination ear drop formulation developed by Med Manor Organics, primarily used to soften, loosen, and facilitate the removal of impacted earwax (cerumen) while relieving associated ear pain and discomfort. It contains four active ingredients: paradichlorobenzene, chlorobutanol, turpentine oil, and lidocaine. Paradichlorobenzene acts as a cerumenolytic agent to dissolve and soften hardened earwax. Chlorobutanol serves as a preservative with mild antiseptic and local anesthetic properties. Turpentine oil acts as a lubricating agent to help dislodge the softened wax and produces a warming sensation that helps relieve pain. Lidocaine is a local anesthetic that blocks voltage-gated sodium channels to prevent the transmission of pain signals from the ear canal to the brain, providing rapid relief from localized pain and irritation.
- Brand names
- Otoid
- Other names
- Otoid Ear Dropschlorbutol + lignocaine + paradichlorobenzene + turpentine oil
02
Targets
NaV (Voltage-gated sodium channels)
Beyond the preview
Go deeper on chlorobutanol + lidocaine + paradichlorobenzene + turpentine oil.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on chlorobutanol + lidocaine + paradichlorobenzene + turpentine oil.